Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo). [electronic resource]
- Biochemical and biophysical research communications Sep 1988
- 1221-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0006-291X
10.1016/s0006-291x(88)81270-1 doi
Acetates--metabolism Acetic Acid Acetylation Adenocarcinoma--metabolism Cell Line Colonic Neoplasms--metabolism Doxorubicin--pharmacology Drug Resistance Histones--metabolism Humans Leucine--metabolism